Co-Administration of GnRH-Agonists with Adjuvant Chemotherapy in Young Breast Cancer Patients: The Effect on Ovarian Function and on Clinical Outcome

被引：0
|
作者：
Goldberg, H.
Stern, M.
Risel, S.
Kuten, A.
Evron, E.
Peretz, T.
Katz, D.
机构：
[1] Western Galilee Hosp, Nahariyya, Israel
[2] Meir Med Ctr, Kefar Sava, Israel
[3] Rabin Med Ctr, Petah Tiqwa, Israel
[4] Rambam Med Ctr, Haifa, Israel
[5] Assaf Harofeh Med Ctr, Zerifin, Israel
[6] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P2-14-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-14-04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?
    Kim, Jiyoung
    Kim, Minkook
    Lee, Jun Ho
    Lee, Hyunchul
    Lee, Se Kyung
    Bae, Soo Youn
    Jun, Si-Youl
    Kil, Won Ho
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    BREAST, 2014, 23 (05): : 670 - 675
  • [2] Molecular Evidence Against Ovarian Protection with the Co-Administration of GNRH Agonist with Chemotherapy in Human.
    Bildik, Gamze
    Akin, Nazli
    Senbabaoglu, Filiz
    Selek, Ugur
    Iwase, Akira
    Oktem, Ozgur
    REPRODUCTIVE SCIENCES, 2016, 23 : 343A - 343A
  • [3] OVARIAN-FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    ROSE, DP
    DAVIS, TE
    LANCET, 1977, 1 (8023): : 1174 - 1176
  • [4] GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients
    Park, Hyun Jung
    Koo, Young-Ah
    Im, Young Hyuck
    Yoon, Byung-Koo
    Choi, DooSeok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (01) : 110 - 116
  • [5] Controversies about the usefulness of GnRH agonists in ovarian protection during chemotherapy for breast cancer
    Rousset-Jablonski, C.
    Dagousset, I.
    ONCOLOGIE, 2012, 14 (6-7) : 386 - 394
  • [6] OVARIAN-FUNCTION AND ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    STOLL, BA
    LANCET, 1978, 1 (8074): : 1159 - 1159
  • [7] CLINICAL PROFILES OF PREMENOPAUSAL BREAST CANCER PATIENTS DURING TAMOXIFEN TREATMENT AFTER ADJUVANT CHEMOTHERAPY WITH GnRH AGONIST FOR OVARIAN PROTECTION.
    Kim, N. Y.
    Lee, D. -Y.
    Kim, M. J.
    Choi, D.
    FERTILITY AND STERILITY, 2010, 94 (04) : S190 - S190
  • [8] Preservation of ovarian function with goserelin in young breast cancer patients: Does it hamper the effect of neoadjuvant chemotherapy?
    Wang, S. Y.
    Wang, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S52 - S52
  • [9] Changes in Markers of Ovarian Reserve and Endocrine Function in Young Women With Breast Cancer Undergoing Adjuvant Chemotherapy
    Yu, Bo
    Douglas, Nataki
    Ferin, Michel J.
    Nakhuda, Gary S.
    Crew, Katherine
    Lobo, Rogerio A.
    Hershman, Dawn L.
    CANCER, 2010, 116 (09) : 2099 - 2105
  • [10] OVARIAN-FUNCTION AND RECURRENCES WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    SCHMIDTGOLLWITZER, K
    SCHONEGG, W
    SCHEIBER, A
    WESSEL, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1987, 47 (10) : 695 - 699
12345